RESEARCH ON HIGH ALCOHOL CONTENT MALT BEVERAGES AND RELATED PRODUCTS
Release Date: January 30, 2001
RFA: RFA-AA-01-003
National Institute on Alcohol Abuse and Alcoholism
(http://www.niaaa.nih.gov/)
Letter of Intent Receipt Date: April 16, 2001
Application Receipt Date: May 14, 2001
THIS (REQUEST FOR APPLICATIONS (RFA) USES THE MODULAR GRANT" AND
"JUST-IN-TIME" CONCEPTS. IT INCLUDES DETAILED MODIFICATIONS TO STANDARD
APPLICATION INSTRUCTIONS THAT MUST BE USED WHEN PREPARING APPLICATIONS IN
RESPONSE TO THIS RFA/PA.
PURPOSE
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks grant
applications to conduct exploratory and developmental research on high alcohol
content malt and wine specialty consumption as risk factors for alcohol-
related health and social problems in racially, ethnically and economically
diverse communities. The most popular of the malt beverages is known as malt
liquor . For the purpose of this RFA, the beverages of interest are those with
an alcohol content above 5 percent, often sold in similar containers as malt
and wine cooler products having an alcohol content of 5 percent or lower.
Previous studies of consumption patterns (quantity, frequency and type of
beverage consumed) have often failed to consider these beverages. This has
resulted in underestimates of the quantity of alcohol consumed and an
imprecise understanding of what is considered a drink . The high alcohol
content of these beverages, often about 7 percent or more, raises special
concerns: 1) for their potential appeal to younger, often under-age drinkers,
2) because they are thought to be primarily, but not exclusively, marketed in
predominantly urban minority communities, and 3) because promotional materials
appear to target the minority youth market. Malt liquor is also relatively
low cost per ounce of absolute alcohol and is often packaged in large-volume
(40 ounce and larger), sometimes, non-recloseable, containers that encourage
more immediate consumption. Community groups have alleged that these
beverages are associated with faster consumption, a high blood alcohol
content, and a more frequent loss of control and aggressive behavior than
other, more standard alcoholic beverages. For example, one community passed a
resolution that requests that off-sale outlet operators voluntarily withdraw
the sale of malt liquor. The community has alleged, largely on the basis of
citizen complaints, that malt liquor consumption contributes significantly to
alcohol related problems in the community.
Little research-based information is available about the association between
the consumption of these beverages and the development of a spectrum of anti-
social and risky behaviors. This RFA will support research that adds to our
knowledge of the consumption patterns of these beverages and adverse health
and social outcomes, if any. It is hoped that the results of this research
will form the basis for the development of effective interventions and
prevention approaches.
HEALTHY PEOPLE 2010
The Public Health Service (PHS) is committed to achieving the health promotion
and disease prevention objectives of "Healthy People 2010," a PHS-led national
activity for setting priority areas. This Request for Applications (RFA)
RESEARCH ON HIGH ALCOHOL CONTENT MALT BEVERAGES AND RELATED PRODUCTS, is
related to one or more of the priority areas. Potential applicants may obtain
a copy of "Healthy People 2010" at http://www.health.gov/healthypeople/
ELIGIBILITY REQUIREMENTS
Applications may be submitted by domestic for-profit and non-profit
organizations, public and private, such as universities, colleges, hospitals,
laboratories, units of State and local governments, and eligible agencies of
the Federal government. Foreign institutions are not eligible for
exploratory/developmental grants under this RFA. Racial/ethnic minority
individuals, women, and persons with disabilities are encouraged to apply as
Principal Investigators.
MECHANISM OF SUPPORT
This RFA will use the National Institutes of Health (NIH)
Exploratory/Developmental Research Grant (R21) award mechanism.
Exploratory/Developmental Research Grants supported under this RFA may request
up to $100,000 per year (direct costs) for up to three years. Responsibility
for the planning, direction, and execution of the proposed project will be
solely that of the applicant. The R21 awards are not renewable. However, we
expect successful exploratory/developmental project awardees supported through
this RFA to subsequently submit regular research project grant (R01)
applications.
Applications for competitive supplements to existing R01 research grants for
up to $100,000 (direct costs) a year for up to three years may also be
accepted. Applicants for a supplement to an existing grant should assure that
the grant meets the requirements to be supplemented. The time frame for
competing supplements cannot exceed the parent grant project period.
Applicants should consult the program administrator before submitting a
competing supplement application under this RFA.
Specific application instructions have been modified to reflect "MODULAR
GRANT" and "JUST-IN-TIME" streamlining efforts being examined by the NIH.
Complete and detailed instructions and information on Modular Grant
applications can be found at
http://grants.nih.gov/grants/funding/modular/modular.htm
This RFA is a one-time solicitation. The anticipated award date is September
28, 2001
FUNDS AVAILABLE
The National Institute on Alcohol Abuse and Alcoholism plans to spend up to $1
million in FY 2001 to fund 7 to 10 new grants under this RFA. An applicant may
request a project period of up to three years and a budget for direct costs of
up to $100,000 per year for an R21 or a competitive supplement to an existing
grant. Because the nature and scope of the research proposed might vary, it
is anticipated that the size of each award will also vary. Although the
financial plans of the Institute provide support for this program, awards
pursuant to this RFA are contingent upon the availability of funds and the
receipt of a sufficient number of applications of outstanding scientific and
technical merit.
RESEARCH OBJECTIVES
Background
Alcoholism and alcohol-related problems have an enormous impact on our
society. Most adults can drink alcohol moderately and responsibly without
complications. However, nearly 14 million Americans meet the medical criteria
for a diagnosis of alcohol abuse or alcoholism. Although a dollar figure
cannot adequately reflect the social and human devastation caused by these
illnesses, it is estimated that the economic and health care costs to society
from alcoholism and alcohol abuse are nearly $185 billion annually. Much of
this cost is related to lost productivity, motor vehicle crashes, alcohol-
related medical expenses and crime.
Why some people who drink get into trouble from alcohol use, while many others
do not, has been a central question in alcohol research. It is clear that
there are genetic influences on an individual"s risk for alcoholism, but
environmental influences are also key factors. African, Hispanic and Native
Americans are at higher risk than whites for certain alcohol-related health
and social problems and alcohol is the number one substance of abuse used by
American adolescents and young adults. Research suggests that causal processes
leading to alcohol use and abuse among youth do not necessarily differ across
ethnic groups but prevalence of factors that affect development of risk does.
Consumption of low cost per ounce, higher alcoholic content (5 percent or
more) malt beverages and other often sweetened alcoholic beverages, especially
among younger adolescents, is of concern because they may contribute to
increased alcohol use and abuse and increased risk. These products are higher
in potency than regular beer or wine coolers, which have alcohol contents of 5
percent alcohol or less and are usually sold in 12 ounce and smaller
containers.
KEY CONCEPTS, MEASURES, AND METHODS
Issues surrounding higher alcohol content malt and wine specialties have been
identified as areas where research-based information on possible associations
with social, psychological, economic and other adverse consequences is
lacking. Little research-based information exists to link outcomes
specifically to consumption of these beverages, independent of other
beverages. This request encourages applicants to consider a broad range of
approaches and methods. Methods and approaches that the Institute believes
will further this effort include: Case control, quantitative, qualitative,
econometric, consumer behavior and longitudinal studies, surveys, natural
experiments, event analyses, multivariate analyses and analyses of marketing
practices and advertising content and sales. Rigorous studies of socially
disruptive activities including fighting, missing school, risky sexual
behaviors, accidents and violent behaviors are also of interest. Research is
needed to determine: if these alcoholic beverages are more available in
ethnically diverse communities, if levels of consumption are higher in these
communities, if advertising, marketing and packaging contribute to higher
consumption levels and what the adverse consequences might be, if any.
The following areas illustrate suitable topics for research. While applicants
are not limited to these themes, they are advised to consult with program
staff on the relevance of their research plans to the RFA.
A. Studies are needed to ascertain:
1) Prevalence
- The evidence of problems directly or indirectly associated with consumption
of these beverages
- Definable pathways leading to consumption of these beverages.
2) User characteristics
- The age, gender, ethnicity and product knowledge of consumers
- Consumers terminology for this beverage
- Awareness of its alcohol content and its influence on their decision to
drink these beverages
3) The degree of harm
- Provide demographic information on populations likely to consume these
beverages versus populations that are likely to consume more traditional beer,
wine or distilled spirits.
- Compare product availability in selected communities.
- Collect and analyze information on national marketing practices in minority
communities.
- Evaluate differences in consumatory practices and social settings of malt
liquor and high alcohol content wine specialty drinkers and drinkers of
comparable products such as beer.
4) Consequences/outcomes
- Effects of consumption of these beverages on health, crime, violence and
other adverse outcomes.
- Compare outcomes in neighborhoods with similar demographics where these
beverages are and are not sold.
- Studies using biological measures to determine physiologic effects, studies
of quantity and frequency of consumption, including blood alcohol
concentrations, in comparison to other alcoholic beverages.
5) Drinking patterns
- Prevalence of chugging and bingeing. Amounts typically consumed and
relationship, if any, to socioeconomic status.
- Consumers definition of a drink .
- Youth trends in mixing malt liquor and other alcoholic beverages or drugs
(e.g. blunts ).
- Role of malt liquor as a gateway to drink other alcoholic beverages.
- Consumer expectancies for different beverages, including malt liquor.
- Consumers expectations of a different high from these beverages.
- Drinker expectancies related to advertising.
6) Social Acceptability
- Social norms regarding drinking in public vs. private.
- Cultural differences among youth groups.
- Differences in Hispanic and Native Americans as compared to African American
youth and adult groups.
- Presence of collective efficacy, the level of social control and/or
willingness of individuals in a neighborhood to intervene in non-sanctioned
behaviors.
7) Marketing strategies
- Advertising promotional strategies specific for these beverages.
- The potential of ads displaying images of strength and power to attract
specific types of drinkers (male bias). Characterize the use of cultural icons
to market these beverages (African, Native, Hispanic Americans).
- Perceptions of these beverages among their drinkers.
- The role of sponsorship (music, etc.)
B. To Evaluate Policy Issues- Effects of changes in alcohol laws
1) Availability
- Outlet-density differences for these beverages versus other alcoholic
beverages (e.g., shelf space dedicated to such products).
- Selling locations by geography and area.
- Quantity of sales by location.
- Effects of on-site versus off site outlets.
- Issues regarding access by minors.
- Control/zoning issues, including presence/absence of enforcement.
- Data to support maintaining or changing policies regarding
marketing/advertising of these beverages.
2) Price/Taxation
- Effects of price and the relationship of statewide pricing to sales volume.
- Price differences in products according to neighborhood/SES.
- Effects due to container size for 40 ounce sometimes non-resealable
containers.
- Effects of price/taxation on consumption/outcomes.
3) Labeling/Definitions
- Consumer awareness of the alcohol content of these beverages and influence
of perceived alcohol content on consumer’s decision to drink malt liquor.
SPECIAL REQUIREMENTS
An annual meeting will be held in the Washington, D.C., area to facilitate the
exchange of information and coordination among investigators. Applicants
should include support for these required meetings as part of the overall
budget request.
INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS
It is the policy of the NIH that women and members of minority groups and
their sub-populations must be included in all NIH-supported biomedical and
behavioral research projects involving human subjects, unless a clear and
compelling rationale and justification are provided indicating that inclusion
is inappropriate with respect to the health of the subjects or the purpose of
the research. This policy results from the NIH Revitalization Act of 1993
(Section 492B of Public Law 103-43).
All investigators proposing research involving human subjects should read the
UPDATED "NIH Guidelines for Inclusion of Women and Minorities as Subjects in
Clinical Research," published in the NIH Guide for Grants and Contracts on
August 2, 2000
(http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-048.html),
a complete copy of the updated Guidelines are available at
http://grants.nih.gov/grants/funding/women_min/guidelines_update.htm: The
revisions relate to NIH defined Phase III clinical trials and require: a) all
applications or proposals and/or protocols to provide a description of plans
to conduct analyses, as appropriate, to address differences by sex/gender
and/or racial/ethnic groups, including subgroups if applicable, and b) all
investigators to report accrual, and to conduct and report analyses, as
appropriate, by sex/gender and/or racial/ethnic group differences.
INCLUSION OF CHILDREN AS PARTICIPANTS IN RESEARCH INVOLVING HUMAN SUBJECTS
It is the policy of NIH that children (i.e., individuals under the age of 21)
must be included in all human subjects research, conducted or supported by the
NIH, unless there are scientific and ethical reasons not to include them.
This policy applies to all initial (Type 1) applications submitted for receipt
dates after October 1, 1998.
All investigators proposing research involving human subjects should read the
"NIH Policy and Guidelines" on the Inclusion of Children as Participants in
Research Involving Human Subjects that was published in the NIH Guide for
Grants and Contracts, March 6, 1998, and is available at the following URL
address: http://grants.nih.gov/grants/guide/notice-files/not98-024.html
Investigators also may obtain copies of these policies from the program staff
listed under INQUIRIES. Program staff may also provide additional relevant
information concerning the policy.
URLS IN NIH GRANT APPLICATIONS OR APPENDICES
All applications and proposals for NIH funding must be self-contained within
specified page limitations. Unless otherwise specified in an NIH
solicitation, internet addresses (URLs) should not be used to provide
information necessary to the review because reviewers are under no obligation
to view the Internet sites. Reviewers are cautioned that their anonymity may
be compromised when they directly access an Internet site.
LETTER OF INTENT
Prospective applicants are asked to submit a letter of intent that includes a
descriptive title of the proposed research, the name, address, and telephone
number of the Principal Investigator, the identities of other key personnel
and participating institutions, and the number and title of the RFA in
response to which the application may be submitted. Although a letter of
intent is not required, is not binding, and does not enter into the review of
a subsequent application, the information that it contains allows IC staff to
estimate the potential review workload and plan the review.
The letter of intent is to be sent to:
RFA-AA-01-003
Extramural Project Review Branch
National Institute on Alcohol Abuse and Alcoholism
6000 Executive Boulevard, Room 409, MSC 7003
Bethesda, MD 20892-7003
Rockville, MD 20852 (for express/courier service)
Telephone: (301) 443-4375 FAX: (301) 443-6077 by the letter of intent receipt
date listed.
APPLICATION PROCEDURES
The research grant application form PHS 398 (rev. 4/98) is to be used in
applying for these grants. These forms are available at most institutional
offices of sponsored research and from the Division of Extramural Outreach and
Information Resources, National Institutes of Health, 6701 Rockledge Drive,
MSC 7910, Bethesda, MD 20892-7910, telephone 301/710-0267, email:
GrantsInfo@nih.gov.
SPECIFIC INSTRUCTIONS FOR MODULAR GRANT APPLICATIONS
The modular grant concept establishes specific modules in which direct costs
may be requested as well as a maximum level for requested budgets. Only
limited budgetary information is required under this approach. The
just-in-time concept allows applicants to submit certain information only when
there is a possibility for an award. It is anticipated that these changes will
reduce the administrative burden for the applicants, reviewers and Institute
staff. The research grant application form PHS 398 (rev. 4/98) is to be used
in applying for these grants, with the modifications noted below.
BUDGET INSTRUCTIONS
Modular Grant applications for Exploratory/Developmental (R21) Grants and
competing supplements will request direct costs in $25,000 modules, up to a
total direct cost request of $100,000 per year for up to three years. The
total direct costs must be requested in accordance with the program guidelines
and the modifications made to the standard PHS 398 application instructions
described below:
PHS 398
o FACE PAGE: Items 7a and 7b should be completed, indicating Direct Costs (in
$25,000 increments up to a maximum of $100,000) and Total Costs [Modular Total
Direct plus Facilities and Administrative (F&A) costs] for the initial budget
period Items 8a and 8b should be completed indicating the Direct and Total
Costs for the entire proposed period of support.
o DETAILED BUDGET FOR THE INITIAL BUDGET PERIOD - Do not complete Form Page 4
of the PHS 398. It is not required and will not be accepted with the
application.
o BUDGET FOR THE ENTIRE PROPOSED PERIOD OF SUPPORT - Do not complete the
categorical budget table on Form Page 5 of the PHS 398. It is not required and
will not be accepted with the application.
o NARRATIVE BUDGET JUSTIFICATION - Prepare a Modular Grant Budget Narrative
page. (See http://grants.nih.gov/grants/funding/modular/modular.htm for sample
pages.) At the top of the page, enter the total direct costs requested for
each year. This is not a Form page.
o Under Personnel, list all project personnel, including their names, percent
of effort, and roles on the project. No individual salary information should
be provided. However, the applicant should use the NIH appropriation language
salary cap and the NIH policy for graduate student compensation in developing
the budget request.
For Consortium/Contractual costs, provide an estimate of total costs (direct
plus facilities and administrative) for each year, each rounded to the nearest
$1,000. List the individuals/organizations with whom consortium or contractual
arrangements have been made, the percent effort of all personnel, and the role
on the project. Indicate whether the collaborating institution is foreign or
domestic. The total cost for a consortium/contractual arrangement is included
in the overall requested modular direct cost amount. Include the Letter of
Intent to establish a consortium.
Provide an additional narrative budget justification for any variation in the
number of modules requested.
o BIOGRAPHICAL SKETCH - The Biographical Sketch provides information used by
reviewers in the assessment of each individual"s qualifications for a specific
role in the proposed project, as well as to evaluate the overall
qualifications of the research team. A biographical sketch is required for all
key personnel, following the instructions below. No more than three pages may
be used for each person. A sample biographical sketch may be viewed at:
http://grants.nih.gov/grants/funding/modular/modular.htm
- Complete the educational block at the top of the form page,
- List position(s) and any honors,
- Provide information, including overall goals and responsibilities, on
research projects ongoing or completed during the last three years.
- List selected peer-reviewed publications, with full citations,
o CHECKLIST - This page should be completed and submitted with the
application. If the F&A rate agreement has been established, indicate the type
of agreement and the date. All appropriate exclusions must be applied in the
calculation of the F&A costs for the initial budget period and all future
budget years.
o The applicant should provide the name and phone number of the individual to
contact concerning fiscal and administrative issues if additional information
is necessary following the initial review.
The RFA label available in the PHS 398 (rev. 4/98) application form must be
affixed to the bottom of the face page of the application. Type the RFA
number on the label. Failure to use this label could result in delayed
processing of the application such that it may not reach the review committee
in time for review. In addition, the RFA title and number must be typed on
line 2 of the face page of the application form and the YES box must be
marked.
The sample RFA label available at:
http://grants.nih.gov/grants/funding/phs398/label-bk.pdf has been modified to
allow for this change. Please note this is in pdf format.
Submit a signed, typewritten original of the application, including the
Checklist, and three signed, photocopies, in one package to:
CENTER FOR SCIENTIFIC REVIEW
NATIONAL INSTITUTES OF HEALTH
6701 ROCKLEDGE DRIVE, ROOM 1040, MSC 7710
BETHESDA, MD 20892-7710
BETHESDA, MD 20817 (for express/courier service)
At the time of submission, two additional copies of the application must be
sent to:
RFA: AA-01-003
Extramural Project Review Branch
National Institute on Alcohol Abuse and Alcoholism
6000 Executive Boulevard, Suite 409, MSC 7003
Bethesda, MD 20892-7003
Rockville, MD 20852 (for express/courier service)
Applications must be received by the application receipt date listed in the
heading of this RFA. If an application is received after that date, it will
be returned to the applicant without review.
The Center for Scientific Review (CSR) will not accept any application in
response to this RFA that is essentially the same as one currently pending
initial review, unless the applicant withdraws the pending application. The
CSR will not accept any application that is essentially the same as one
already reviewed. This does not preclude the submission of substantial
revisions of applications already reviewed, but such applications must include
an introduction addressing the previous critique.
REVIEW CONSIDERATIONS
Upon receipt, applications will be reviewed for completeness by the CSR and
responsiveness by the NIAAA. If the application is not responsive to the RFA,
CSR staff may contact the applicant to determine whether to return the
application to the applicant or submit it for review in competition with
unsolicited applications at the next review cycle.
Applications that are complete and responsive to the RFA will be evaluated for
scientific and technical merit by an appropriate peer review group convened by
the NIAAA in accordance with the review criteria stated below. As part of the
initial merit review, a process will be used by the initial review group in
which applications receive a written critique and undergo a process in which
only those applications deemed to have the highest scientific merit, generally
the top half of the applications under review, will be discussed, assigned a
priority score, and receive a second level review by the National Advisory
Council on Alcohol Abuse and Alcoholism.
Review Criteria
The goals of NIH-supported research are to advance our understanding of
biological systems, improve the control of disease, and enhance health. In
the written comments reviewers will be asked to discuss the following aspects
of the application in order to judge the likelihood that the proposed research
will have a substantial impact on the pursuit of these goals. Each of these
criteria will be addressed and considered in assigning the overall score,
weighting them as appropriate for each application. Note that the application
does not need to be strong in all categories to be judged likely to have major
scientific impact and thus deserve a high priority score. For example, an
investigator may propose to carry out important work that by its nature is not
innovative but is essential to move a field forward.
(1) Significance: Does this study address an important problem? If the aims
of the application are achieved, how will scientific knowledge be advanced?
What will be the effect of these studies on the concepts or methods that drive
this field?
(2) Approach: Are the conceptual framework, design, methods, and analyses
adequately developed, well-integrated, and appropriate to the aims of the
project? Does the applicant acknowledge potential problem areas and consider
alternative tactics?
(3) Innovation: Does the project employ novel concepts, approaches or method?
Are the aims original and innovative? Does the project challenge existing
paradigms or develop new methodologies or technologies?
(4) Investigator: Is the investigator appropriately trained and well suited
to carry out this work? Is the work proposed appropriate to the experience
level of the principal investigator and other researchers (if any)?
(5) Environment: Does the scientific environment in which the work will be
done contribute to the probability of success? Do the proposed experiments
take advantage of unique features of the scientific environment or employ
useful collaborative arrangements? Is there evidence of institutional
support?
In addition to the above criteria, in accordance with NIH policy, all
applications will also be reviewed with respect to the following:
o The adequacy of plans to include both genders, minorities and their
subgroups, and children as appropriate for the scientific goals of the
research. Plans for the recruitment and retention of subjects will also be
evaluated.
o The reasonableness of the proposed budget and duration in relation to the
proposed research.
o The adequacy of the proposed protection for humans, animals or the
environment, to the extent they may be adversely affected by the project
proposed in the application.
o The adequacy of the proposed plan to share data, if appropriate.
Additional consideration pertinent to the review of Exploratory/Developmental
Grant (R21) applications:
Pilot/feasibility studies may contain little or no preliminary data. Review
should focus on whether the rationale for the study is well developed and
whether the proposed research is likely to generate data that will lead to a
regular research project grant or full-scale clinical trial. Adequate
justification for the proposed work may be provided through literature
citations, data from other sources, or investigator-generated data.
Schedule
Letter of Intent Receipt Date: April 16, 2001
Application Receipt Date: May 14, 2001
Peer Review Date: July, 2001
Council Review: September 18, 2001
Earliest Anticipated Start Date: September 28, 2001
AWARD CRITERIA
Award criteria that will be used to make award decisions include:
o scientific merit (as determined by peer review)
o availability of funds
o programmatic priorities.
INQUIRIES
Inquiries concerning this RFA are encouraged. The opportunity to clarify any
issues or answer questions from potential applicants is welcome.
Direct inquiries regarding programmatic issues to:
Ernestine Vanderveen, Ph.D.
Office of Collaborative Research
National Institute on Alcohol Abuse and Alcoholism
6000 Executive Blvd, Suite 302, MCS 7003
Bethesda, MD 20892-7003
Telephone: (301) 443-2531
FAX (301) 480-2358
Email: tvanderv@willco.niaaa.nih.gov
Direct inquiries regarding review issues to:
Tony Beck, Ph.D.
Extramural Project Review Branch
National Institute on Alcohol Abuse and Alcoholism
6000 Executive Blvd, Suite 409, MCS 7003
Bethesda, MD 20892-7003
Telephone: (301) 443-0913
FAX (301) 443-6077
Email: lbeck@mail.nih.gov
Direct inquiries regarding fiscal matters to:
Linda Hilley
Grants Management Branch
National Institute on Alcohol Abuse and Alcoholism
6000 Executive Blvd, Suite 504, MCS 7003
Bethesda, MD 20892-7003
Telephone: (301) 443-0915
FAX (301) 480-3891
Email: lhilley@willco.niaaa.nih.gov
AUTHORITY AND REGULATIONS
This program is described in the Catalog of Federal Domestic Assistance No.
93.273. Awards are made under authorization of Sections 301 and 405 of the
Public Health Service Act as amended (42 USC 241 and 284) and administered
under NIH grants policies and Federal Regulations 42 CFR 52 and 45 CFR Parts
74 and 92. This program is not subject to the intergovernmental review
requirements of Executive Order 12372 or Health Systems Agency review.
The PHS strongly encourages all grant recipients to provide a smoke-free
workplace and promote the non-use of all tobacco products. In addition,
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain
facilities (or in some cases, any portion of a facility) in which regular or
routine education, library, day care, health care, or early childhood
development services are provided to children. This is consistent with the
PHS mission to protect and advance the physical and mental health of the
American people.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
|
|
|
Department of Health and Human Services (HHS)
|
|
|
|
NIH... Turning Discovery Into Health®
|